Genentech’s Investigational Antibody Wins BTD for Alzheimer’s Treatment
Genentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read more
Latest
Tezepelumab gets ODD in the US for Eosinophilic Esophagitis
Tezepelumab, developed by AstraZeneca in collaboration with Amgen, has been granted Orphan Drug Designation (ODD) in the US FDA for
Read more
WHO Endorses GlaxoSmithKline’s Breakthrough Malaria Vaccine
The World Health Organization on Wednesday endorsed the groundbreaking GlaxoSmithKline Malaria vaccine for children at risk reinvigorating the fight against
Read more
Merck and Ridgeback’s Oral Antiviral Molnupiravir Can Halve COVID-19 Risk of Hospitalisation
Interim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization
Read more
FDA OK’s Tecartus® CAR T-cell Therapy for B-cell Acute Lymphoblastic Leukemia
Kite Pharma, a Gilead Company, announced on Friday that the U.S. FDA has granted approval for CAR T-cell therapy Tecartus®
Read more
Rosalind Franklin Institute, Novel Biological Imaging Technologies, UK
The Rosalind Franklin Institute, a new research institute dedicated to developing novel technologies to tackle important health research challenges has
Read more
FDA Approves Antibody-drug Conjugate TIVDAK™ for Recurrent or Metastatic Cervical Cancer
Genmab A/S and Seagen Inc. revealed that the first and only approved antibody-drug conjugate (ADC) known as TIVDAK™ (tisotumab vedotin-tftv),
Read more
FDA Committee Recommends COMIRNATY® Booster for Emergency Use in People 65+
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee
Read more
Valneva Stock Price Drops 40% as UK cancels vaccine deal
Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
Read more
NHS Starts Blood Test Trial to Detect More Than 50 Types of Cancer
The NHS-Galleri Trial is being launched to evaluate whether a blood test may help identify cancer earlier when combined with
Read more